Therapy of patients with breast cancer with anxiety and depressive disorders
https://doi.org/10.25789/YMJ.2020.69.08
Abstract
Female patients with histologically verified breast cancer, including newly diagnosed breast cancer and with a history of 3-17 years were under study. In the clinical picture of the examined patients, depressive, anxious-phobic and psycho-somatic disorders were identified, which significantly reduced their quality of life and adversely affected the prognosis and survival of patients. Conducting specialized pharmacotherapy with the use of antidepressants in combination with benzodiazepine drugs and hypnotics in breast cancer patients revealed high efficacy of the combination therapy.
About the Authors
O. V. Shushpanova
Mental Health Research Center of the Russian Academy of Sciences
Russian Federation
Russian Federation
SHUSHPANOVA Olga Vladimirovna – Researcher
34 Kashirskoye Shosse, 115522, Moscow
S. V. Ivanov
Mental Health Research Center of the Russian Academy of Sciences
Russian Federation
Russian Federation
IVANOV Stanislav Viktorovich – PhD, MD, Professor, Chief Researcher
34 Kashirskoye Shosse, 115522, Moscow
T. V. Shushpanova
Mental Health Research Institute “Tomsk National Research Medical Center of the Russian Academy of Sciences”
Russian Federation
Russian Federation
SHUSHPANOVA Tamara Vladimirovna – PhD., MD, Leading Scientific Researcher
634014, Tomsk, Aleutskaya 4
References
1. Volodin B.Yu. Psychosomatic relationships in cancer patients. /B.Yu. Volodin //Palliative medicine and rehabilitation. – 2007. – № 3. – рр. 51-54.
2. Galiullina S.D. Neuropsychiatric disorders in patients with breast cancer: Abstract dis. cand. med. sciences / S.D. Galiullina – Ufa, 2000. – 23 p.
3. Malignant neoplasms in Yakutia (morbidity and mortality) / under P.M. Ivanov, L.N. Afanasieva, S.A. Myreeva ed. – Yakutsk, 2018. – 180 p.
4. Samushia M. A. Nosogeny (psychogenic reactions) in breast cancer / M.A. Samushia, I.V. Zubova // Mental disorders in general medicine. – 2009. – № 1. – P. 24-29.
5. Malignant neoplasms in Russia in 2015 (morbidity and mortality) / under A.D. Kaprin, V.V. Starinsky, G.V. Petrova ed. – M., 2017. – 250 p.
6. Shushpanova O.V. Mental disorders in patients with breast cancer: a differentiated approach to the study of nosogeny / O.V. Shushpanova, S.S. Korsakov // Journal of Neurology and Psychiatry. – 2017. – V.117 (8). – pp. 18–26. doi: 10.17116/jnevro20171178118-26.
7. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients / S. Sanjida, M. Janda, D. Kissane [et al.] // Psychooncology. – 2016. – V. 25(9). – pp. 1002-1016. doi: 10.1002/pon.4048.
8. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. / P. Butow, S. Kelly, B. Thewes [et al.] // Psychooncology. – 2015. – V. 24(4). – pp. 416-423. doi: 10.1002/pon.3659.
9. Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors. N. Biglia, V. E Bounous, T. Susini [et al]. // Eur. J. Cancer Care (Engl). – 2018. – 27(1). doi: 10.1111/ecc.12484.
10. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy / J. A Roscoe., G. R Morrow., J. T. Hickok [et al.] // Breast Cancer Res. Treat. – 2005. – V. 89(3). – pp. 243-249. doi: 10.1007/s10549-004-2175-1.
11. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review / L. Grassi, R. Caruso, K. Hammelef [et al.] // Int. Rev. Psychiatry. – 2014. – V. 26(1). – pp. 44–62. doi: 10.3109/09540261.2013.84254.
12. Ersoy M.A. An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients / M. A. Ersoy, A. M. Noyan, H. Elbi // Clin Drug Investig. – 2008. – V. 28(2). – pp. 113–20. doi: 10.2165/00044011-200828020-00005.
13. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology / D. S. Baldwin, I. M. Anderson, D. J. Nutt [et al.] // J. Psychopharmacol. – 2014. – V. 28(5). – pp. 403–439. doi: 10.1177/0269881114525674.
14. Frampton J. E. Duloxetine: a review of its use in the treatment of major depressive disorder / J.E Frampton, G.L. Plosker // CNS Drugs. – 2007. – V. 21. – pp. 581-609. doi:10.2165/00023210-200721070-00004.
15. Interactions between antidepressants, sleep aids and selected breast cancer therapy / J. J. Wedret, T.G. Tum, D. Paul [et al.] // Ment Illn. – 2019. – V. 11(1). – pp. 8115. doi: 10.4081/mi.2019.8115.
16. Irarrázaval O.M.E. Antagonism of tamoxifen and antidepressants among women with breast cancer. / O.M.E. Irarrázaval // Rev. Med. Chil. –2011. – V. 139(1). – pp. 89-99. doi: 10.4067/S0034-98872011000100013.
17. Kalso E. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. / E. Kalso, T. Tasmuth, P.J. Neuvonen // Pain. 1996; 64(2): 293-302. doi:10.1016/0304-3959(95)00138-7.
18. Liebowitz M.R. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder / M.R. Liebowitz, A.J. Gelenberg, D. Munjack //Arch Gen Psychiatry. 2005; 62:190-198. doi: 10.1001/archpsyc.62.2.190.
19. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials / A.F. Carvalho, T. Hyphantis, P.M. Sales [et al.] // Cancer Treat Rev. – 2014. – V. 40(3). – pp. 349-355. doi: 10.1016/j.ctrv.2013.09.009
20. Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract / F. Caraci, R. Crupi, F. Drago [et al.] // Current Drug Metabolism. – 2011. – V. 12(6). – pp. 570-577. doi:10.2174/138920011795713706
21. Navari R.M. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy / R.M. Navari, M.C. Brenner, M.N. Wilson // Breast Cancer Res Treat. – 2008. – V.112(1). – pp. 197–201. doi: 10.1007/s10549-007-9841-z.
22. Pharmacogenetics of escitalopram and mental adaptation to cancer in palliative care: report of 18 cases / G. Schillani, M.A. Capozzo, D. Era [et al.] // Tumori. – 2011. – V. 97(3). – 358–361. doi: 10.1700/912.10034.
23. Pezzella G. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline / G.Pezzella, R. Moslinger-Gehmayr, A. Contu A. // Breast Cancer Res. Treat. – 2001. – V. 70(1). – pp.1-10. doi: 10.1023/a:1012518831494.
24. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. / G.G. Kimmick, J. Lovato, R. McQuellon [et al.] // Breast J. – 2006. – V.12(2). – pp. 114-122. doi: 10.1111/j.1075-122X.2006.00218.x
25. Rustad J.K. Cancer and post-traumatic stress disorder: diagnosis, pathogenesis and treatment considerations / J.K. Rustad, D. David, M.B. Currier // Pall Supp Care. – 2012. – V. 10(3). – pp. 213–223. doi: 10.1017/S1478951511000897.
26. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. / I. Wiśniewska, B. Jochymek, M. Lenart-Lipińska [et al.] // Breast Cancer. – 2016. – V. 23. – pp. 178–182. doi: 10.1007/s12282-015-0655-2.
27. The use of antidepressants in oncology: a review and practical tips for oncologists. / L. Grassi, M.G. Nanni, G. Rodin [et al.] // Ann Oncol. – 2018. – V. 29(1). – pp. 101-111. doi: 10.1093/annonc/mdx526.
28. Torta R. Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial / R. Torta, P. Leombruni, R. Borio R., Castelli L. // Hum. Psychopharmacol. – 2011. – V. 26. – pp. 291-299. doi: 10.1002/hup.1202.
29. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis / R. Ramaswami, M. D. Villarreal, D. M. Pitta [et al.] // Breast Cancer Res. Treat. – 2015. – V. 152(2). – pp. 231-237. doi: 10.1007/s10549-015-3465-5.
Review
For citations:
Shushpanova O.V., Ivanov S.V., Shushpanova T.V. Therapy of patients with breast cancer with anxiety and depressive disorders. Yakut Medical Journal. 2020;(1):34-38. https://doi.org/10.25789/YMJ.2020.69.08
Views:
8
Email this article 